VBI Vaccines (VBIV) Short Interest Ratio & Short Volume → Charles Payne Demystifies Options (From Unstoppable Prosperity) (Ad) Free VBIV Stock Alerts $0.61 +0.01 (+1.67%) (As of 01:12 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability VBI Vaccines Short Interest DataCurrent Short Volume709,500 sharesPrevious Short Volume289,100 sharesChange Vs. Previous Month+145.42%Dollar Volume Sold Short$411,510.00Short Interest Ratio / Days to Cover1.6Last Record DateApril 15, 2024Outstanding Shares28,682,000 sharesFloat Size26,740,000 sharesShort Percent of Float2.65%Today's Trading Volume15,988 sharesAverage Trading Volume346,614 sharesToday's Volume Vs. Average5% Short Selling VBI Vaccines ? Sign up to receive the latest short interest report for VBI Vaccines and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVBIV Short Interest Over TimeVBIV Days to Cover Over TimeVBIV Percentage of Float Shorted Over Time Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. VBI Vaccines Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024709,500 shares $411,510.00 +145.4%2.7%1.6 $0.58 3/31/2024289,100 shares $174,211.66 -4.6%1.3%0.8 $0.60 3/15/2024302,900 shares $169,836.03 -3.4%1.4%2.4 $0.56 2/29/2024313,500 shares $181,830.00 -15.7%1.4%2.4 $0.58 2/15/2024371,700 shares $223,057.17 +20.4%1.7%2.7 $0.60 1/31/2024308,800 shares $216,160.00 +7.0%1.4%2.8 $0.70 Get the Latest News and Ratings for VBIV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024288,700 shares $176,135.87 -3.8%1.3%2.5 $0.61 12/31/2023300,200 shares $176,367.50 +0.1%1.4%2.5 $0.59 12/15/2023300,000 shares $186,900.00 +11.9%1.4%1.9 $0.62 11/30/2023268,100 shares $164,935.12 -42.1%1.2%1.4 $0.62 11/15/2023463,000 shares $287,986.00 +107.2%2.1%2.2 $0.62 10/31/2023223,500 shares $131,887.35 -20.2%1.0%1.1 $0.59 10/15/2023280,100 shares $156,856.00 -36.9%1.3%1.2 $0.56 9/30/2023443,900 shares $295,726.18 +161.7%2.1%1.1 $0.67 9/15/2023169,600 shares $186,560.00 +28.5%0.8%0.1 $1.10 8/31/2023132,000 shares $161,040.00 -15.6%0.6%0.1 $1.22 8/15/2023156,300 shares $200,064.00 -35.8%0.7%0.1 $1.28 7/31/2023243,600 shares $319,116.00 -39.4%1.1%0.2 $1.31 7/15/2023402,000 shares $534,660.00 +66.4%5.4%0.3 $1.33 6/30/2023241,600 shares $794,864.00 -49.8%3.0%0.2 $3.29 6/15/2023481,300 shares $1.24 million -10.0%5.9%3.7 $2.58 5/31/2023534,500 shares $1.59 million -5.2%6.6%4.9 $2.97 5/15/2023564,000 shares $1.74 million +8.4%7.0%5.5 $3.09 4/30/2023520,200 shares $1.49 million -1.4%6.4%5.4 $2.87 4/15/2023527,700 shares $1.69 million -0.9%6.5%6.5 $3.20 3/31/2023532,200 shares $3.23 million -96.5%6.6%9.7 $6.06 3/15/202315,050,000 shares $5.00 million +8.7%6.2%16.2 $0.33 2/28/202313,840,000 shares $6.64 million +3.0%5.7%14.7 $0.48 2/15/202313,440,000 shares $7.34 million +4.1%5.5%13.4 $0.55 1/31/202312,910,000 shares $7.51 million +7.0%5.3%12.5 $0.58 1/15/202312,070,000 shares $6.70 million +1.9%5.0%12.2 $0.56 12/30/202211,850,000 shares $4.63 million -1.6%4.9%12.5 $0.39 12/15/202212,040,000 shares $5.90 million -6.4%4.9%14.5 $0.49 11/30/202212,860,000 shares $6.69 million -6.3%5.3%14.7 $0.52 11/15/202213,730,000 shares $9.39 million +3.9%5.6%16.7 $0.68 10/31/202213,210,000 shares $9.51 million -5.2%5.4%14.8 $0.72 10/15/202213,930,000 shares $9.14 million -1.1%5.7%14 $0.66 9/30/202214,090,000 shares $9.94 million -4.0%5.8%11.5 $0.71 9/15/202214,670,000 shares $12.07 million +3.1%6.0%10.3 $0.82 8/31/202214,230,000 shares $12.74 million -4.6%5.8%6.8 $0.901970’s computer coder Issues Shocking AI Warning (Ad)Louis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP VBIV Short Interest - Frequently Asked Questions What is VBI Vaccines' current short interest? Short interest is the volume of VBI Vaccines shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 709,500 shares of VBIV short. 2.65% of VBI Vaccines' shares are currently sold short. Learn More on VBI Vaccines' current short interest. What is a good short interest ratio for VBI Vaccines? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VBIV shares currently have a short interest ratio of 2.0. Learn More on VBI Vaccines's short interest ratio. What is a good short interest percentage for VBI Vaccines? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.65% of VBI Vaccines' floating shares are currently sold short. Is VBI Vaccines' short interest increasing or decreasing? VBI Vaccines saw a increase in short interest in April. As of April 15th, there was short interest totaling 709,500 shares, an increase of 145.4% from the previous total of 289,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is VBI Vaccines' float size? VBI Vaccines currently has issued a total of 28,682,000 shares. Some of VBI Vaccines' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. VBI Vaccines currently has a public float of 26,740,000 shares. How does VBI Vaccines' short interest compare to its competitors? 2.65% of VBI Vaccines' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to VBI Vaccines: Minerva Neurosciences, Inc. (0.56%), Aytu BioPharma, Inc. (7.51%), Vincerx Pharma, Inc. (8.91%), Indaptus Therapeutics, Inc. (1.46%), NeuroSense Therapeutics Ltd. (0.76%), Talphera, Inc. (0.65%), Vaxxinity, Inc. (9.31%), Tonix Pharmaceuticals Holding Corp. (1.76%), Orgenesis Inc. (1.17%), Aptorum Group Limited (1.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short VBI Vaccines stock? Short selling VBIV is an investing strategy that aims to generate trading profit from VBI Vaccines as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VBI Vaccines? A short squeeze for VBI Vaccines occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VBIV, which in turn drives the price of the stock up even further. How often is VBI Vaccines' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VBIV, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NERV Short Interest AYTU Short Interest VINC Short Interest INDP Short Interest NRSN Short Interest TLPH Short Interest VAXX Short Interest TNXP Short Interest ORGS Short Interest APM Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VBIV) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm Press348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 Media